🇺🇸 Interleukin 2 Receptor Antagonist in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Arterial Ligation — 1 report (10%)
  2. Ascites — 1 report (10%)
  3. Cholestasis — 1 report (10%)
  4. Complications Of Transplant Surgery — 1 report (10%)
  5. Complications Of Transplanted Liver — 1 report (10%)
  6. Cyst Rupture — 1 report (10%)
  7. Cytomegalovirus Infection — 1 report (10%)
  8. Diarrhoea — 1 report (10%)
  9. Enterobacter Pneumonia — 1 report (10%)
  10. Haemodialysis — 1 report (10%)

Source database →

Interleukin 2 Receptor Antagonist in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Interleukin 2 Receptor Antagonist approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Interleukin 2 Receptor Antagonist in United States?

University of Khartoum is the originator. The local marketing authorisation holder may differ — check the official source linked above.